🔍

NAVINFLUOR - Navin Fluo.Intl.

📊 NSE: NAVINFLUOR 🏢 Chemicals 📅 Last Updated: 12/14/2025 10:21

📢 Recent Corporate Announcements

Navin Fluorine Q3 FY26 PAT Jumps 122% to ₹185 Cr; Revenue Up 47% YoY

🟢 POSITIVE ⭐ 9/10

EARNINGS 📅 13 Feb 2026, 11:19 AM

Navin Fluorine reported a stellar Q3 FY26 performance with revenue growing 47% YoY to ₹892 crores, driven by strong growth across all business verticals. The company's EBITDA margins expanded significantly to 34.5%, up from 24.3% in the previous year, reflecting strong operating leverage and better realizations. Notably, the Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 crores, while the CDMO business grew by 61% YoY. With the successful commissioning of Wave-1 CAPEX projects and a healthy pipeline for Wave-2, the company remains well-positioned for sustainable growth.

Consolidated Revenue for Q3 FY26 rose 47% YoY to ₹892 crores, surpassing full-year FY25 revenue within nine months.
Net Profit (PAT) surged 122% YoY to ₹185 crores, with EBITDA margins expanding by 1,020 bps to 34.5%.
Specialty Chemicals vertical recorded its highest-ever quarterly revenue of ₹354 crores, a 60% YoY increase.
Successfully commissioned cGMP-4 Phase-1 and AHF projects, marking the completion of Wave-1 CAPEX.
Maintained a strong balance sheet with a net debt-to-equity ratio of 0.03x and working capital below 80 days.

💡 Investors should view this as a strong growth signal given the massive margin expansion and successful execution of CAPEX projects. The stock remains a high-conviction play in the specialty fluorochemicals and CDMO space with clear revenue visibility.

Navin Fluorine Q3FY26: Revenue up 47% YoY to ₹892 Cr, EBITDA jumps 109%

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 10 Feb 2026, 06:29 PM

Navin Fluorine reported a robust Q3FY26 with consolidated revenue growing 47% YoY to ₹892.4 crore. Operating EBITDA saw a significant surge of 109% YoY to ₹307.6 crore, with margins expanding by 1017 bps to 34.5%. Growth was driven by strong performance across Specialty Chemicals (+60% YoY), CDMO (+61% YoY), and HPP (+35% YoY) segments. The company is also progressing on several capex projects, including HFC expansion and MPP de-bottlenecking, aimed at future growth.

Consolidated Revenue for Q3FY26 grew 47% YoY to ₹892.4 crore and 18% Q-o-Q.
Operating EBITDA margin expanded significantly to 34.5%, up from 24.3% in the previous year.
Specialty Chemicals revenue reached its highest-ever quarter at ₹354 crore, up 60% YoY.
CDMO business grew 61% YoY to ₹127 crore with strong order visibility for CY26 and beyond.
Announced ₹236.5 crore capex for additional HFC capacity (R32) with a peak revenue potential of ₹600-825 crore.

💡 Investors should note the significant margin expansion and strong performance across all three business verticals. The stock remains a key play in the fluorination space with visible growth from upcoming capex in HFC and Specialty Chemicals.

Navin Fluorine Q3FY26: Revenue Jumps 47% to ₹892 Cr, EBITDA Surges 109% with Strong Margins

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 10 Feb 2026, 05:32 PM

Navin Fluorine reported a robust Q3FY26 performance with consolidated revenue growing 47% YoY to ₹892.4 crore and Operating EBITDA surging 109% YoY to ₹307.6 crore. Operating EBITDA margins expanded significantly by 1017 bps YoY to 34.5%, driven by higher realizations and volumes across Specialty and HPP segments. The company is executing major capex projects, including a ₹236.5 crore HFC expansion and a ₹75 crore de-bottlenecking project, both targeted for Q3FY27. The CDMO business also showed strong momentum with 61% YoY growth and a positive outlook for CY26.

Consolidated Q3FY26 Revenue grew 47% YoY to ₹892.4 Cr; Operating EBITDA rose 109% to ₹307.6 Cr.
Operating EBITDA margin reached 34.5%, up 1017 bps YoY and 201 bps Q-o-Q.
Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 Cr, up 60% YoY.
New HFC capacity capex of ₹236.5 Cr is on track for Q3FY27 with a peak revenue potential of ₹600-825 Cr.
CDMO segment revenue increased 61% YoY to ₹127 Cr with strong order visibility from European majors.

💡 Investors should take note of the significant margin expansion and the aggressive capex roadmap which provides high revenue visibility through FY27. The stock remains a strong candidate for long-term portfolios focused on the specialty chemicals and CDMO sectors.

Navin Fluorine Releases Q3 FY26 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Feb 2026, 08:15 PM

Navin Fluorine International Limited has made the audio recording of its Q3 FY 2025-26 earnings call available to the public. The call, held on February 09, 2026, discussed the company's operational and financial performance for the quarter ended December 31, 2025. This is a standard regulatory disclosure under SEBI LODR Regulations to ensure transparency for all shareholders. Investors can access the full recording via the link provided on the company's official website.

Audio recording of the earnings call for Q3 FY 2025-26 is now available online.
The call was held on February 09, 2026, following the announcement of quarterly results.
Management discussed operational and financial performance for the period ending December 31, 2025.
The disclosure complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 Investors should listen to the recording to gain insights into management's commentary on margin trends and the progress of new capital expenditure projects. No immediate action is required as this is a routine disclosure.

Navin Fluorine Q3 FY26: Revenue up 47% YoY to ₹892 Cr, EBITDA Margins Expand to 34.5%

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 09 Feb 2026, 05:10 PM

Navin Fluorine reported a robust Q3 FY26 with consolidated revenue growing 47% YoY to ₹892.4 crore, driven by strong performance across all business verticals. Operating EBITDA surged 109% YoY to ₹307.6 crore, with margins expanding significantly by 1017 bps to 34.5%. The Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 crore, while the CDMO and HPP segments grew by 61% and 35% respectively. The company is aggressively investing in capex, including a ₹236.5 crore HFC expansion and ₹75 crore MPP de-bottlenecking, both targeted for Q3 FY27.

Consolidated Revenue grew 47% YoY to ₹892.4 Cr; PAT increased 122% YoY to ₹185.4 Cr.
Operating EBITDA margin expanded significantly to 34.5% from 24.3% in the previous year.
Specialty Chemicals segment recorded its highest-ever quarterly revenue of ₹354 Cr, up 60% YoY.
CDMO business showed strong momentum with 61% YoY growth and robust order visibility for Q4 and beyond.
Announced HFC (R32) capex of ₹236.5 Cr with a peak revenue potential of ₹600-825 Cr per annum.

💡 Investors should consider this a strong performance update, highlighting successful execution in high-margin segments and clear visibility for future growth through massive capex. The significant margin expansion and 'highest-ever' specialty revenue suggest a structural improvement in profitability.

Navin Fluorine CHRO Pankaj Lochan Resigns Effective February 27, 2026

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 09 Feb 2026, 05:01 PM

Navin Fluorine International Limited has announced the resignation of Mr. Pankaj Lochan from the position of Chief Human Resource Officer (CHRO). His resignation will be effective from the close of business hours on February 27, 2026. The departure is attributed to his personal and professional plans. The company has already initiated a search for a suitable senior professional to fill this key leadership role.

Mr. Pankaj Lochan to step down as Chief Human Resource Officer on February 27, 2026
Resignation is driven by personal and professional plans according to the official filing
The company has formally initiated a search for a successor for the CHRO position
Transition period of approximately 18 days provided from the date of announcement (Feb 9 to Feb 27)

💡 This is a routine management change at the functional head level and does not warrant immediate action. Investors should monitor if there are further exits in the senior leadership team which could signal organizational instability.

Navin Fluorine CHRO Pankaj Lochan Resigns Effective February 27, 2026

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 09 Feb 2026, 04:56 PM

Mr. Pankaj Lochan, the Chief Human Resource Officer (CHRO) of Navin Fluorine International Limited, has tendered his resignation effective February 27, 2026. The departure is attributed to his personal and professional plans, and the company has already initiated a search for a suitable senior professional to fill the role. This transition follows a formal notice period starting from February 9, 2026, to ensure a smooth handover of responsibilities. While senior management changes are important, the CHRO role is typically less impactful on immediate financial performance than CEO or CFO transitions.

Mr. Pankaj Lochan to step down as Chief Human Resource Officer effective February 27, 2026
Resignation letter submitted on February 9, 2026, citing personal and professional plans
Company has initiated a search for a new senior professional for the CHRO position
Transition period of approximately 18 days provided to ensure smooth handover of duties

💡 This is a routine management change and requires no immediate action; however, investors should monitor for any further senior-level exits that could suggest broader organizational instability.

Navin Fluorine Q3 FY26 Consolidated PAT Jumps 122% YoY to ₹185 Cr; Revenue Up 47%

🟢 POSITIVE ⭐ 9/10

EARNINGS 📅 09 Feb 2026, 04:39 PM

Navin Fluorine reported a robust performance for Q3 FY26, with consolidated revenue growing 47.2% YoY to ₹892.37 crore. Net profit (PAT) surged by 121.7% YoY to ₹185.40 crore, even after accounting for an exceptional charge of ₹20.47 crore related to new labour code liabilities. The company demonstrated strong sequential momentum, with revenue and PAT increasing 17.6% and 24.9% respectively over Q2 FY26. Additionally, the company confirmed that the ₹750 crore raised via QIP in July 2025 has been fully utilized.

Consolidated Revenue from operations grew 47.2% YoY to ₹892.37 crore from ₹606.20 crore.
Consolidated Profit After Tax (PAT) increased 121.7% YoY to ₹185.40 crore.
Recognized an exceptional item of ₹20.47 crore as incremental liability for employee benefits under New Labour Codes.
Basic EPS rose significantly to ₹36.18 from ₹16.86 in the corresponding quarter last year.
Interim dividend of ₹6.50 per share (325%) was paid during the quarter for FY 2025-26.

💡 The strong top-line and bottom-line growth suggests successful capacity utilization and robust demand in the specialty chemicals segment. Investors should remain positive but monitor the long-term impact of the New Labour Codes on operating margins.

Navin Fluorine Q3 PAT surges 122% YoY to ₹185.4 Cr; Revenue up 47%

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 09 Feb 2026, 04:35 PM

Navin Fluorine reported a strong performance for Q3 FY26, with consolidated revenue from operations growing 47.2% YoY to ₹892.37 crore. Net profit surged by 121.7% YoY to ₹185.40 crore, despite an exceptional charge of ₹20.47 crore related to new labour code compliance. The company maintained its growth momentum with a 17.6% QoQ increase in revenue and a 25% QoQ increase in PAT. Notably, nine-month revenue has already exceeded the total revenue for the previous full financial year.

Consolidated Revenue from Operations grew 47.2% YoY to ₹892.37 crore in Q3 FY26.
Consolidated PAT increased by 121.7% YoY to ₹185.40 crore, with EPS rising to ₹36.18 from ₹16.86.
Reported an exceptional loss of ₹20.47 crore due to incremental liability from New Labour Codes.
9M FY26 revenue reached ₹2,376.19 crore, surpassing the full FY25 revenue of ₹2,349.38 crore.
The company paid an interim dividend of ₹6.50 per share (325% on face value) during the quarter.

💡 Investors should maintain a positive outlook as the company demonstrates strong operational leverage and significant growth in its core chemical business. The robust 9M performance and successful utilization of QIP funds indicate a strong growth trajectory for the full year.

Navin Fluorine Commences Commercial Production of 40,000 TPA AHF Plant at Dahej

🟢 POSITIVE ⭐ 8/10

EXPANSION 📅 06 Feb 2026, 02:46 PM

Navin Fluorine International Limited has successfully commissioned its new Anhydrous Hydrofluoric Acid (AHF) manufacturing plant at Dahej as of February 06, 2026. The facility has a significant production capacity of 40,000 tonnes per annum, which was built with a capital expenditure of ₹450 crores. This project, originally announced in March 2023, is now fully operational and entering the commercial production phase. This expansion is expected to enhance the company's backward integration capabilities and support its specialty chemicals business.

Commenced commercial production of a new 40,000 tonnes per annum hydrofluoric acid capacity
Total capital expenditure for the project amounted to ₹450 crores
Facility is located at the Navin Fluorine Advanced Sciences Limited site in Dahej
Successful commissioning follows the initial investment announcement made on March 17, 2023

💡 Investors should view this as a positive growth catalyst that strengthens the company's supply chain and margin profile. Monitor the utilization rates of this new capacity in upcoming quarterly reports to gauge revenue impact.

Navin Fluorine Allots 6,600 Equity Shares Under ESOP Scheme 2017

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 05 Feb 2026, 02:49 PM

Navin Fluorine International Limited has announced the allotment of 6,600 equity shares to employees who exercised their options under the Employees’ Stock Option Scheme 2017. This routine corporate action results in a marginal increase in the company's paid-up share capital to ₹10,24,89,088. The new shares will rank pari-passu with the existing equity shares. The total number of fully paid-up equity shares now stands at 5,12,40,514.

Allotment of 6,600 equity shares of face value ₹2 each under ESOP 2017
Paid-up share capital increased to ₹10,24,89,088
Total share count includes 5,12,40,514 fully paid and 8,060 partly paid shares
New shares rank pari-passu with existing equity shares in all respects

💡 This is a routine administrative update with negligible equity dilution; no specific action is required from investors.

Navin Fluorine Schedules Q3 FY26 Earnings Call for February 9, 2026

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 03 Feb 2026, 04:32 PM

Navin Fluorine International Limited has scheduled its earnings conference call for the third quarter and nine months of FY 2025-26 on February 9, 2026, at 6:30 PM IST. The management team, including the Chairman, Managing Director, and CFO, will discuss the company's financial and operational performance for the period ended December 31, 2025. This call is a standard procedure following the quarterly results to provide deeper insights into business segments and future outlook. Investors can access the call via the provided primary dial-in numbers or international toll-free lines.

Earnings call scheduled for Monday, February 9, 2026, at 18:30 IST.
Discussion to focus on Q3 and 9M FY26 operational and financial performance.
Key management participants include Chairman Vishad Mafatlal and MD Nitin Kulkarni.
Primary dial-in numbers for the call are +91 22 6280 1550 and +91 22 7115 8378.
International toll-free access available for HK, Singapore, USA, and UK investors.

💡 Investors should monitor the call for management's commentary on the recovery of the specialty chemicals segment and updates on capital expenditure projects. Pay close attention to guidance regarding margin sustainability amidst global supply chain shifts.

Navin Fluorine Q2 FY26 PAT Jumps 152% YoY to ₹148 Cr; EBITDA Margins Expand to 32.5%

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 03 Feb 2026, 04:20 PM

Navin Fluorine reported a robust Q2 FY26 with consolidated revenue growing 46% YoY to ₹758.4 crore, driven by strong performance across CDMO (+98%) and Specialty Chemicals (+39%). Operating EBITDA surged 129% YoY to ₹246.2 crore, with margins expanding significantly by 1176 bps to 32.5%. The company also announced new capex of ₹236.5 crore for HFC capacity and ₹75 crore for MPP de-bottlenecking, targeting a combined peak revenue potential of nearly ₹1,000 crore per annum.

Consolidated Net Revenue for Q2 FY26 rose 46% YoY to ₹758.4 crore, while H1 FY26 revenue grew 42% to ₹1,483.8 crore.
CDMO business vertical showed the highest growth, nearly doubling (+98%) to ₹134 crore in Q2 FY26.
Operating EBITDA margins improved sharply to 32.5% in Q2 FY26 from 20.7% in the same quarter last year.
Announced ₹236.5 crore capex for R32 HFC capacity with a peak revenue potential of ₹600-825 crore per annum.
Net Profit (PAT) for the quarter stood at ₹148.37 crore, representing a 152% increase over Q2 FY25.

💡 The strong margin recovery and aggressive capex plans indicate a positive growth trajectory; investors should monitor the timely commissioning of the R32 and MPP projects by Q3 FY27.

Navin Fluorine Shareholders Approve Kartikeya Dube as Independent Director with 99.96% Majority

🟢 POSITIVE ⭐ 6/10

MANAGEMENT 📅 28 Jan 2026, 08:27 PM

Navin Fluorine International Limited has announced the successful passage of a special resolution to appoint Mr. Kartikeya Dube as an Independent Director. The resolution was approved via a postal ballot process with an overwhelming 99.96% of votes cast in favor. Mr. Dube, who is the Chairman of bp Group of Companies in India, brings over 30 years of experience in finance, M&A, and the energy sector. This appointment, effective from December 3, 2025, is expected to strengthen the company's board governance and strategic oversight.

Special resolution for the appointment of Mr. Kartikeya Dube passed with 99.9575% votes in favor.
A total of 37,787,936 valid votes were polled during the remote e-voting period ending January 28, 2026.
Mr. Dube brings 30+ years of experience and currently serves as Chairman of bp Group of Companies, India.
The appointment is for a fixed term and the director is not liable to retire by rotation.
Only 0.0425% of the total votes (16,055 votes) were cast against the resolution.

💡 Investors should view this as a positive governance move that adds significant industrial and financial expertise to the board. No immediate trading action is required as this is a routine but high-quality management reinforcement.

Navin Fluorine Assigned ESG Rating Score of 66.7 by SES ESG Research

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 24 Jan 2026, 02:35 PM

SES ESG Research Private Limited has independently assigned an ESG rating score of 66.7 to Navin Fluorine International Limited. The company clarified that it did not commission this report, as it was prepared based on data available in the public domain. This rating provides a third-party assessment of the company's environmental, social, and governance practices. Such disclosures are increasingly important for institutional investors and ESG-mandated funds.

SES ESG Research assigned an ESG Rating score of 66.7 to the company.
The rating was independently prepared using publicly available data without company engagement.
The disclosure was made in compliance with Regulation 30 of SEBI Listing Regulations.
The rating report was communicated to the company on January 23, 2026.

💡 Investors should monitor this score relative to industry peers to gauge the company's sustainability standing. No immediate action is required as this is an informational third-party assessment.

View All NAVINFLUOR Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue for H1 FY26 rose 42% to INR 1,484 Cr. Q2 FY26 revenue grew 46% to INR 758 Cr. The High-Performance Products (HPP) segment achieved 38% YoY growth in Q2 FY26, crossing INR 400 Cr. In FY23, high-value segments (Specialty Chemicals and CDMO) grew 30% YoY, though they saw a decline of 30% and 13% respectively in FY24 due to industry headwinds.

Geographic Revenue Split

Exports accounted for 56% of total revenue in FY25. Key international markets include North America, Europe, the Middle East, and Asia Pacific, while the remaining 44% is derived from domestic Indian operations.

Profitability Margins

Operating margins have shown volatility; PBILDT margin improved from 24.4% in FY22 to 26.6% in FY23, but moderated to 19.40% in FY24 and 19.16% in Q1 FY25 due to pricing pressures in export refrigerants and a shift in business mix. Gross profit margins remained stable in Q2 FY26, with earnings growth driven by operating leverage.

EBITDA Margin

EBITDA for H1 FY26 more than doubled compared to H1 FY25. The company faces a negative rating trigger if PBILDT margins fall below 20% on a sustained basis, while a positive trigger is set for achieving an operating ROCE above 28%.

Capital Expenditure

The company is executing large-sized, partly debt-funded projects. A Qualified Institutional Placement (QIP) of INR 750 Cr was completed in July 2025, primarily to reduce debt in its subsidiary, Navin Fluorine Advanced Sciences Limited (NFASL), and support ongoing value-accretive capex expected to drive growth beyond FY27.

Credit Rating & Borrowing

Long-term bank facilities of INR 210.10 Cr are rated CARE AA; Stable (reaffirmed Sept 2025). Short-term facilities of INR 230.10 Cr are rated CARE A1+. Borrowing costs are supported by a strong financial risk profile with a net debt-to-equity ratio of 0.9x as of September 30, 2025.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Fluorspar (accounting for over 40% of total raw material costs), Chloroform, and Sulphur.

Import Sources

Fluorspar is primarily sourced from South Africa and China. The company has specifically entered long-term contracts with South African miners to de-risk its supply chain from Chinese volatility.

Key Suppliers

Not disclosed in available documents beyond general references to South African miners.

Capacity Expansion

The company operates a Multipurpose Plant (MPP) and is focusing on debottlenecking to drive higher asset sweating. Dedicated capex for specific molecules is considered as volumes scale. New projects in the NFASL subsidiary have recently commenced operations to expand the fluorine value chain.

Raw Material Costs

Raw material costs are highly volatile, particularly Fluorspar. While the company has historically passed on cost increases to customers, there is a time lag that can temporarily squeeze margins.

Manufacturing Efficiency

Efficiency is driven by operating leverage, as seen in Q2 FY26 where revenue grew 46% while operating costs increased only 12%.

📈 Strategic Growth

Expected Growth Rate

42%

Growth Strategy

Growth is targeted through a focus on high-value CDMO and Specialty Chemical verticals, leveraging R&D in complex fluorine chemistry. The company is utilizing a 'Navin Molecular' brand to expand CDMO services beyond fluorination and has secured multi-year contracts with global innovators to ensure revenue visibility.

Products & Services

Refrigerant gases (including R32 and HFOs), inorganic fluorides, specialty fluorides, and CDMO services for pharmaceutical and agrochemical intermediates.

Brand Portfolio

MAFRON (refrigerant gases), Navin Molecular (CDMO business).

New Products/Services

Expansion into HFO (Hydrofluoroolefins) and R32 refrigeration gases to replace older HCFC products; new product pipelines in R&D are expected to accelerate growth from FY27 onwards.

Market Expansion

Targeting growth in North America and Europe through the CDMO vertical and high-performance products.

Market Share & Ranking

One of the largest specialty fluorochemical companies in India and a pioneer in refrigerant gas manufacturing.

Strategic Alliances

Strategic multi-year partnerships with global players for supplying intermediates in the pharma and agrochemical industries.

🌍 External Factors

Industry Trends

The industry is shifting toward low-GWP (Global Warming Potential) refrigerants like HFOs due to environmental regulations. Navin is positioning itself by increasing the share of high-value specialty chemicals and CDMO services which are less commoditized.

Competitive Landscape

Faces competition in certain business segments and pricing pressure in the export market for refrigerant gases.

Competitive Moat

Moat is built on complex fluorine chemistry expertise, R&D capabilities, and long-standing relationships with global innovators. These are sustainable due to the high technical barriers and hazardous nature of fluorine handling.

Macro Economic Sensitivity

Sensitive to global pharmaceutical and agrochemical demand cycles, as these end-user industries drive the CDMO and Specialty Chemical segments.

Consumer Behavior

Increasing demand for sustainable and 'Responsible Care' certified chemical suppliers among global pharmaceutical and agrochemical majors.

Geopolitical Risks

Exposure to trade barriers and supply chain disruptions due to the high percentage of exports and reliance on imported Fluorspar.

⚖️ Regulatory & Governance

Industry Regulations

Subject to environmental norms regarding the production and phase-out of ozone-depleting substances (HCFCs) and manufacturing standards for hazardous chemicals.

Environmental Compliance

The company holds 'Responsible Care' certification and has released its third sustainability report in 2025. It faces risks from the regulatory phase-out of HCFCs.

Legal Contingencies

Secretarial Audit Reports for FY25 for NFIL and its material subsidiary NFASL contained no qualifications, reservations, or adverse remarks.

⚠️ Risk Analysis

Key Uncertainties

Volatility in Fluorspar prices (40% of RM cost) and potential delays in realizing returns from large-scale capex projects (ROCE target >14% to avoid rating downgrade).